Zielinski CM - Search Results

1

The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).

Byfield PE, Barth CL, Brodie JA, Cosimi AB, Dienst SG, Elberg AJ, Elfring GL, Hardy MA, Hayashi H, Kountz SL, Lamborn KR, Loughman BE, Sakai A, Satoh PS, Zielinski CM, Wechter WJ. Byfield PE, et al. Among authors: zielinski cm. Transplant Proc. 1978 Sep;10(3):627-31. Transplant Proc. 1978. PMID: 362648 No abstract available.

2

Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.

Kountz SL, Butt KH, Rao TK, Zielinski CM, Rafi M, Schultz JR. Kountz SL, et al. Among authors: zielinski cm. Transplant Proc. 1977 Mar;9(1):1023-5. Transplant Proc. 1977. PMID: 325728 No abstract available.

3

Trends in immunosuppression for kidney transplantation.

Butt KM, Zielinski CM, Parsa I, Elberg AJ, Wechter W, Kountz SL. Butt KM, et al. Among authors: zielinski cm. Kidney Int Suppl. 1978 Jun;(8):S95-8. Kidney Int Suppl. 1978. PMID: 357820 No abstract available.

4

Patient self-referral for kidney transplantation.

Kountz SL, Hong JH, Yellin JA, Ashby MW, Zielinski CM, Butt KM. Kountz SL, et al. Among authors: zielinski cm. Trans Am Soc Artif Intern Organs. 1977;23:422-6. doi: 10.1097/00002480-197700230-00110. Trans Am Soc Artif Intern Organs. 1977. PMID: 333697

5

ATG overdose in a kidney-grafted patient. Clinical course and possible implications.

Zlabinger GJ, Pohanka E, Doleschel W, Zielinski C, Wolf H, Kovarik J. Zlabinger GJ, et al. Transpl Int. 1988 Oct;1(3):168-71. doi: 10.1007/BF00348842. Transpl Int. 1988. PMID: 3075477

6

Anti-thymocyte globulin overdosage--risk or potential benefit?

Zlabinger GJ, Pohanka E, Doleschel W, Zielinski C, Wolf H, Kovarik J. Zlabinger GJ, et al. Am J Med. 1988 Feb;84(2):369-70. doi: 10.1016/0002-9343(88)90448-2. Am J Med. 1988. PMID: 3044074 No abstract available.

7

Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.

Reitter EM, Ay C, Kaider A, Pirker R, Zielinski C, Zlabinger G, Pabinger I. Reitter EM, et al. Clin Exp Immunol. 2014 Jul;177(1):253-60. doi: 10.1111/cei.12308. Clin Exp Immunol. 2014. PMID: 24580121 Free PMC article.

8

[Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].

Zielinski C, Müller C, Smolen J. Zielinski C, et al. Acta Med Austriaca. 1988;15(5):155-8. Acta Med Austriaca. 1988. PMID: 3064527 Clinical Trial. German.

9

Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features.

Kaufmann H, Ackermann J, Greinix H, Nösslinger T, Gisslinger H, Keck A, Ludwig H, Worel N, Kalhs P, Zielinski C, Drach J. Kaufmann H, et al. Ann Oncol. 2003 Nov;14(11):1667-72. doi: 10.1093/annonc/mdg454. Ann Oncol. 2003. PMID: 14581276 Free article. Clinical Trial.

10

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I, Steger G, Jaeger U, Zielinski C, Pabinger I. Simanek R, et al. J Thromb Haemost. 2010 Jan;8(1):114-20. doi: 10.1111/j.1538-7836.2009.03680.x. Epub 2009 Nov 2. J Thromb Haemost. 2010. PMID: 19889150 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters